Editorial Office of the English-language journal ‘Chinese Journal of Cancer Research’

Chinese Journal of Cancer Research (CN 11-2591/R; ISSN 1000-9604) was founded in 1988 under the China Association for Science and Technology, sponsored by the Chinese Anti-Cancer Association and hosted by Peking University Cancer Hospital. It is now bimonthly and publishes the latest basic, clinical, prevention and control oncology research. Indexed by SCIE in 2008, it was the first domestic oncology journal indexed by SCI; it entered PubMed/PubMed Central in 2012 and is also indexed by Scopus, Chemical Abstracts, EMBASE, CSCD, CSTPCD and CNKI. It was selected for the first and second China Science and Technology Journals International Influence Enhancement Plans in 2013 and 2016 and for the first and second China Excellent Science and Technology Journals Action Plans in 2019 and 2024. It has repeatedly been named one of China's most internationally influential academic journals and high-quality international science journals, and is T1 in the Chinese Association for Science and Technology Oncology Journal Classification Directory (fifth edition, December 2025). Its 2025 impact factor is 6.7, ranked 58/333 (Q1). Honorary editor-in-chief is Professor Zhan Qimin, Academician of the Chinese Academy of Engineering; editor-in-chief is Professor Ke Yang, former director of Peking University Cancer Hospital's Genetics Laboratory and foreign member of the National Academy of Medicine; executive editor-in-chief is Professor Ji Jiafu, chief expert of the hospital's Gastrointestinal Cancer Center, director of the Peking University Cancer Research Center and Academician of the Chinese Academy of Engineering; deputy editor-in-chief is Professor Chen Wanqing, deputy director of the National Cancer Center's Cancer Resources Department and director of the Cancer Registry Office of the Cancer Hospital, Chinese Academy of Medical Sciences. Professors Ding Jian, Lin Dongxin, Xu Binghe and Yu Jinming, Academician Zhang Xuemin of the Chinese Academy of Sciences, and Academician Zhang Zemin serve as advisers. The editorial board has 96 renowned oncology experts from China and abroad; overseas scholars account for nearly 50%, mainly from the United States, Korea, Japan, Italy and the United Kingdom. Website: www.cjcrcn.org; Email: [email protected].